Precision BioSciences (DTIL) Tops Q1 EPS by 181c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of $1.70, $1.81 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $17.58 million versus the consensus estimate of $8.83 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• BofA Securities Starts PhysicsWallah Ltd (PWL:IN) at Underperform
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold